Skip to content

Faculty profile

Wael Elhenawy

Back to faculty
ResearcherMedical Microbiology and ImmunologyUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

Latest papers

  • Neutrophil-derived reactive oxygen species mediate doxorubicin-induced cardiotoxicity and skeletal myopathy.

    American journal of physiology. Heart and circulatory physiology · 2026

  • Rhomboid protease GlpG regulates type 1 pili quality control and virulence in pathogenic E. coli.

    Nature communications · 2025

  • The assembly of a hybrid type IV secretion system by a Crohn's disease-associated Escherichia coli strain.

    Nature communications · 2025 · senior author

All 11 publications

Latest funding

  • The electron transport chain of Pseudomonas aeruginosa and its role in biofilm formation, quorum sensing, and value as an antibiotic target

    CIHR · 2026 · Co-investigator

    $891,226
  • Uncovering biofilm-specific strategies of Crohn's disease-associated Escherichia coli in resisting host defenses

    CIHR · 2025 · Supervisor

    $120,000
  • Deciphering the role of biofilms in Crohn's disease

    CIHR · 2024 · Nominated PI

    $918,000
All 8 grants and awards
Something wrong or missing on this profile? Suggest a correction